Vascepa (icosapent ethyl)

pCPA File Number: 21276
Negotiation Status:
Concluded with an LOI
Indication(s):
Ischemic events in statin-treated patients
Sponsor/Manufacturer:
HLS Therapeutics Inc.
CDA-AMC Project Number:
SR0619-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: